Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof ...

Approved for MDD in 2018, iTBS is a quicker form of repetitive transcranial magnetic stimulation (rTMS), with sessions averaging 3 minutes as compared with 40 minutes for traditional rTMS sessions -- ...

Researchers led by Dr. Roberto Goya-Maldonado at the University Medical Center Göttingen have identified a rapid ...

The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.

In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights ...

It stands for Psychiatric Renewal Through Innovative Solutions and Methods. There are a couple of high profile treatments, ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Julia Hotz, Author of “The Connection Cure”, joins Gayle Guyardo, host of Bloom, to discuss the new health trend called ...

In this randomized clinical trial, the use of a smartphone self-help app was associated with increased self-esteem and ...

Practice these physical, cognitive, and emotional strategies to feel more in control when dysregulation threatens.